VeonGen Therapeutics GmbH - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Why the IMNN-001 and PARP inhibitor pairing could matter more than the standalone data in ovarian cancer

Why VG801 could reshape endpoint strategy in inherited retinal disease development

FDA engagement signals cautious progress for AEON Biopharma Inc. in complex biologics space (NYSE American: AEON)

Representative image of MS Dhoni in an IPL-style cricket setting, used for illustrative purposes alongside coverage of Chennai Super Kings’ early 2026 injury setback.

MS Dhoni ruled out of first two weeks of IPL 2026 with calf strain, CSK face early squad crisis

Read More

5 minute read

Pharma Industry News

Why VG801 could reshape endpoint strategy in inherited retinal disease development

VG801 shows early vision gains in Stargardt disease. Discover how VeonGen Therapeutics is redefining endpoints and regulatory strategy.

bySoujanya Ravi

March 28, 2026

web analytics